Portfolio company
Orbit Genomics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops AI-powered genomic tests for healthcare providers and patients to diagnose lung cancer and evaluate risks for chronic diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
20/20 BioLabs
This company develops AI-powered blood tests for the early detection and prevention of cancers and chronic diseases for individuals and healthcare providers.
Artera
This company develops artificial intelligence tests that predict cancer outcomes and treatment benefits for clinicians and their patients.
Lucid Genomics
This company develops an artificial intelligence platform for long-read genomic data interpretation to assist clinical laboratories and pharmaceutical researchers with diagnostics.
Moonlight AI
This company develops an artificial intelligence diagnostics platform that provides genomic insights from routine blood and marrow smear images for oncology laboratories.
Omica
This company develops artificial intelligence software to screen pathology slides for cancer biomarkers, serving hospital laboratories and biopharmaceutical partners to improve patient therapy selection.
Preview Health
This company develops an artificial intelligence molecular profiling platform to help pharmaceutical companies and clinicians detect diseases and evaluate drug responses through biological samples.
Predicta Biosciences
This company develops blood-based genomic diagnostic tests for clinicians and pharmaceutical partners to monitor and treat blood cancers.
Aidence
This company develops artificial intelligence software for the analysis of chest scans to assist radiologists and hospitals with lung cancer screening.